Prevalence and impact of long COVID on health-related quality of life in previously hospitalized COVID-19 patients: a 2-year follow-up study.

Prevalence and impact of long COVID on health-related quality of life in previously hospitalized COVID-19 patients: a 2-year follow-up study.

Publication date: Dec 11, 2025

Long COVID is a major health concern, yet evidence from Southeast Asia remains limited. We evaluated the prevalence, predictors, and health-related quality of life (HRQoL) impact of long COVID among hospitalized adults in Thailand over two years. This single-center, ambidirectional cohort combined retrospective chart review with prospective follow-up. The cohort comprised 295 adults hospitalized for symptomatic COVID-19 between August and November 2021. Interviews occurred at three months, one year, and two years post-infection. Long-COVID prevalence was 49. 8% at three months; among these, 64. 4% reported persistent symptoms at one year, and 22% of the one-year symptomatic group had symptoms at two years. Common symptoms included breathlessness, fatigue, and memory disturbance. Logistic regression identified severe-critical acute illness as a risk factor (adjusted odds ratio [aOR] 2. 06, 95% CI 1. 23-3. 46), while full vaccination was protective (aOR 0. 48, 95% CI 0. 25-0. 90). Long COVID was associated with lower HRQoL across all EQ-5D-5L domains. Long COVID was frequent among hospitalized Thai patients, with symptoms persisting in a substantial proportion up to two years. Severity of acute COVID-19 and vaccination status predicted long COVID. Long COVID was linked to reduced HRQoL, underscoring the need for follow-up and further confirmation in larger, multicenter studies.

Open Access PDF

Concepts Keywords
August COVID-19
November Long COVID
Severe Prevalence
Thailand Risk factors
Vaccination

Semantics

Type Source Name
disease MESH long COVID
disease MESH COVID-19
disease MESH infection
disease MESH included
disease MESH breathlessness
disease MESH fatigue
pathway REACTOME Reproduction
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH severe acute respiratory syndrome
drug DRUGBANK Oxygen
disease MESH hair loss
disease MESH muscle pain
disease MESH chest pain
disease MESH cough
disease MESH numbness
disease MESH joint pain
disease MESH pain
disease MESH anxiety

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *